# Clinical Trial of Vildagliptin in Early Parkinson's Disease

> **NCT06951334** · NA · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital, Sun Yat-Sen University** · enrollment: 66 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Vildagliptin 50 mg bid

## Key facts

- **NCT ID:** NCT06951334
- **Lead sponsor:** First Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06951334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06951334, "Clinical Trial of Vildagliptin in Early Parkinson's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06951334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*